We are pleased to inform you that at the end of September, a new Acatar Care television campaign was launched. The TV campaign is based on the proven “Vlogerka” brand platform. The advertisement aims to present the new variant in the Acatar brand portfolio – the Acatar Care spray for infectious rhinitis, which is an innovative combination of oxymetazoline and hyaluronic acid in the Polish market.

We invite you to watch the spot.

For more information about the product, please visit the page www.acatar.pl

Acatar Care: Active substance: oxymetazoline. Excipient – hyaluronic acid.

Acatar Care Oxymetazolini hydrochloridum 0.5 mg/ml, nasal spray, solution.

Indications: Swelling of the mucous membranes occurring in acute rhinitis, vasomotor rhinitis, allergic rhinitis, sinusitis, eustachian tube inflammation, otitis media.

Contraindications: Hypersensitivity to the active substance or any of the excipients. Dry inflammation of the nasal mucosa (Rhinitis sicca). In the following cases, the product can only be used after a careful assessment of the benefit-risk ratio: treatment with monoamine oxidase inhibitors (MAO inhibitors) currently or within the last two weeks, and treatment with other drugs that may increase blood pressure; increased intraocular pressure, especially in the case of angle-closure glaucoma; severe heart and blood vessel diseases (e.g., ischemic heart disease, arterial hypertension); pheochromocytoma; metabolic disorders (e.g., hyperthyroidism, diabetes). The product should not be used in patients after transnasal surgical procedures, such as transsphenoidal pituitary removal and surgical procedures with dura mater exposure.

Entity responsible: US Pharmacia Sp. z o.o., 50-507 Wrocław, ul. Ziębicka 40

**Before use, read the leaflet included in the packaging or consult a doctor or pharmacist, as any improperly used medication poses a risk to your life or health.**